United States Zika Virus Diagnostics Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities

Market Size and Growth

Zika virus diagnostics market is expected to reach at a High CAGR during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In February 2025, Dr. Aravinda de Silva and his team introduced a novel blood test for accurate diagnosis of both dengue and Zika viruses. This advancement enhances surveillance capabilities and supports vaccine development efforts.

Japan: Recent Industry Developments

✅ In February 2025, a research team in Japan developed a rapid, low-cost diagnostic test for Zika that delivers results within 20 minutes without the need for specialized laboratory settings. This innovation addresses the limitations of RT-PCR testing, particularly in regions with limited laboratory infrastructure.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/zika-virus-diagnostics-market?sb

Zika virus diagnostics are tests and tools used to detect Zika virus infection in humans, including molecular assays (PCR), serological tests, and rapid detection kits. They enable early diagnosis, guide clinical management, and support public health monitoring and outbreak control.

Recent Mergers and acquisitions:

United States: Recent M&A Activity in Zika Virus Diagnostics

✅ In August 2025, a prominent U.S.-based diagnostic company acquired a smaller firm specializing in rapid Zika virus testing technologies. This strategic move aims to enhance the acquirer's portfolio and expand its market presence in the Zika diagnostics space.

✅ In July 2025, a leading molecular diagnostics company in the U.S. announced the acquisition of a startup focused on multiplex PCR assays for vector-borne diseases, including Zika virus. The acquisition is expected to accelerate the development and commercialization of advanced diagnostic solutions.

✅ In June 2025, a major healthcare conglomerate in the U.S. completed the acquisition of a diagnostics firm with a strong presence in Latin America, aiming to strengthen its position in regions with high Zika virus incidence.

✅ In 2025, the Zika virus diagnostic market in the U.S. experienced moderate M&A activity, with larger diagnostic companies acquiring smaller, agile firms possessing novel technologies. These acquisitions, averaging one significant deal per year over the past three years, were often valued in the tens of millions of dollars.

Japan: Recent M&A Activity in Zika Virus Diagnostics

✅ In May 2025, a Japanese biotechnology company specializing in infectious disease diagnostics acquired a European firm known for its Zika virus detection kits. This acquisition is poised to enhance the company's product offerings and expand its global reach.

✅ In April 2025, a Japanese medical diagnostics company entered into a strategic partnership with a Southeast Asian firm to co-develop a rapid Zika virus diagnostic test, aiming to address the growing demand in endemic regions.

✅ In 2025, Japan's Zika virus detection market saw a moderate level of mergers and acquisitions, driven by companies seeking to expand their product portfolios and enhance diagnostic capabilities

Key Players:

=> CERTEST BIOTEC., altona Diagnostics GmbH, Norgen Biotek Corp., VITROSENS, InBios International, Inc., F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers AG, DiaSorin S.p.A. and TRUPCR Europe Ltd among others.

Growth Forecast Projected:

The Global Zika virus diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Zika virus diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=zika-virus-diagnostics-market

Key Segments:

➥ By Test Kit Type: PCR Based, ELISA Based
➥ By Sample Type: Serum, Whole Blood, Urine, Amniotic Fluid, Others
➥ By End Users: Hospitals & Clinics, Diagnostic Centers, Public Healthcare Centers, Others

Regional Analysis for Zika virus diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Zika virus diagnostics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Zika virus diagnostics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/zika-virus-diagnostics-market?sb

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.